Public Policy Page Contents
- PSAB Documents (Statements, Reports, Testimony and Monthly Newsletters)
- Research and Development Funding for FY 2016
- Clinical Microbiology Resources
- Public and Scientific Affairs Board Information
- Federal and State Government Links
- Congressional Science Fellowship
Check Here for Critical Public Policy Information
- Sentinel Level Clinical Laboratory Protocols For Suspected Biological Threat Agents And Emerging Infectious Diseases
- Committee on the Status of Women in Microbiology
- Committee on Microbiological Issues Impacting Minorities
Public and Scientific Affairs Board (PSAB)
Underlying the ASM's dedication to the advancement of scientific knowledge is its commitment that science serve the public interest. To address scientific matters affecting the public interest, the ASM created the Public and Scientific Affairs Board (PSAB) in 1979. The PSAB monitors legislation and regulation and develops positions for the Society on public policy issues. The PSAB encourages the adoption of sound policies affecting science and technology and the discipline of microbiology. The PSAB responds to policy makers who may request or require an understanding of research and technology in microbiology. It also communicates microbiological issues to the public.
What's New in Public Policy?
The January issue of the Minority Microbiology Mentor has been published by the Committee on Microbiological Issues Impacting Minorities.
December 22, 2015 - White House Releases National Action Plan for Combating Multidrug-Resistant Tuberculosis
The White House released a comprehensive plan that identifies critical actions to be taken by key Federal departments and agencies to combat the global rise of multidrug-resistant tuberculosis (MDR-TB).
December 18, 2015 - Statement of the ASM on the FY 2016 Congressional Funding Increases for Research
Congress passed a $1.1 trillion spending package on December 18 that funds federal agencies for fiscal year 2016. The omnibus appropriations bill (HR 2029) provides $32 billion for the National Institutes of Health (NIH), a $2 billion increase and nearly 7 percent over FY 2015.
The December issue of the e-Public Policy Update has been published by the Office of Public Affairs.
Susan Sharp, ASM President-Elect, presented answers to a series of questions on behalf of ASM to the meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Working Group on One Health Surveillance.
That ASM sent comments to the Office of Science and Technology Policy (OSTP) regarding an a Request for Information (RFI) on Identifying Sources of Agricultural Innovation.
The ASM sent out an advisory to members regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome.
December 2, 2015 - ASM Letter Regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome
The ASM sent a letter to Dr. John Holdren, Director of the Office of Science and Technology Policy and Shaun Donovan, Director of the Office of Management and Budget regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome. The report was published by the Life Sciences Subcommittee...
November 19, 2015 - ASM Comments on Proposed Changes to Human Subject Protection Regulations (Common Rule)
ASM applauds proposed changes in the Human Subject Protection Regulations that would exclude the use of spent, de-identified human specimens for routine validation of diagnostic tests, as well as other quality assurance activities and asks that that this exclusion from oversight be expanded to include all research on de-identified specimens...
President Obama has proclaimed Nov. 16-22 “Get Smart About Antibiotics Week.” Get Smart Week builds on the momentum generated at the White House Forum on Antibiotic Stewardship, where more than 150 organizations pledged to improve antibiotic use and slow the spread of antibiotic resistance.